Dr. Christina Cho, MD – Hackensack, NJ

Overview of Dr. Cho

Dr. Christina Cho is an oncologist in Hackensack, NJ and is affiliated with multiple hospitals in the area, including Hackensack Meridian Health Hackensack University Medical Center and Hackensack Meridian Health Jersey Shore University Medical Center. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 6 years. She is one of 130 doctors at Hackensack Meridian Health Hackensack University Medical Center and one of 41 doctors at Hackensack Meridian Health Jersey Shore University Medical Center who specialize in Oncology. She has more than 60 publications and over 500 citings.

Education & Training

• University of California (San Francisco)Residency, Internal Medicine, 2014

• Columbia University Vagelos College of Physicians and SurgeonsClass of 2011

• Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology

Certifications & Licensure

• CA State Medical License 2013 - Present

• NJ State Medical License 2022 - 2025

• NY State Medical License 2014 - 2025

• American Board of Internal Medicine Internal Medicine
• American Board of Internal Medicine Hematology
• American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

• Inductee Alpha Omega Alpha Honor Medical Society, 2011

Publications & Presentations

PubMed

• Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation.

  Melica, G., Preston, E., Palazzo, M., Seier, K., Malard, F., Devlin, S., Maloy, M., Borrill, T., Cho, C., Maslak, P., Shah, G., Perales, M.> ;Bone Marrow Transplantation. 2024 Feb 13
• 1 citations

  Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT.

  Kattria van der Ploeg, Rosa Sottile, Theodota Kontopoulos, Brian C Shaffer, Genovefa A Papanicolaou, Molly A Maloy, Christina Cho, Kevin S Robinson, Miguel-Angel Peral...> ;Blood Advances. 2023 Oct 10

• Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation.

  Roni Tamari, Michael Scordo, Binni M Kunvarjee, Anthony Proli, Andrew Lin, Jessica Flynn, Christina Cho, Sean Devlin, Elizabeth Klein, Farid Boulad, Maria I Cancio, Ke...> ;Blood Advances. 2023 Sep 26
• Join now to see all

Abstracts/Posters

• Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation

  Christina Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

• Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant Abstract

  Christina Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Professional Memberships

Hospital Affiliations